Virupaksha completes ₹104-crore acquisition of Vivin Drugs
The story in brief
Virupaksha Organics finalized its ₹104-crore acquisition of Vivin Drugs and Vivin Laboratories through NCLT approval. The deal merges both entities under Virupaksha, improving operational efficiency in Hyderabad. Virupaksha plans to launch its IPO next.